Education
About Us
Working with TipRanks
Follow Us
Lifemd, Inc. (LFMD)
:LFMD
LFMD Stock Chart & Stats
Day’s Range― - ―
52-Week Range$3.99 - $12.88
Previous CloseN/A
Volume302.38K
Average Volume (3M)1.63M
Market Cap
$242.09M
Enterprise Value$209.51M
Total Cash (Recent Filing)$38.92K
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta2.03
Next Earnings
May 09, 2025EPS Estimate
-0.05Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.54
Shares Outstanding44,583,687
10 Day Avg. Volume769,812
30 Day Avg. Volume1,630,937
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.18
Price to Cash Flow (P/CF)39.80
P/FCF Ratio275.00
Enterprise Value/Market Cap0.87
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit0.86
Enterprise Value/Ebitda-22.77
Forecast
1Y Price Target
$11.42Price Target Upside110.31% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceLifeMD's total revenue and Telehealth revenue in 4Q24 significantly exceeded projections, indicating strong company performance.
Growth ProspectsManagement expects solid revenue growth in 2025, suggesting confidence in the company's future prospects.
Market PositionLifeMD's comprehensive care platform and new product offerings are anticipated to enhance its market position.
Bears Say
Pricing And Coverage IssuesManagement believes another major challenge for LFMD is patient affordability for the high price of branded GLP-1 drugs when insurance does not cover it.
Regulatory ChallengesThe FDA ruling that Novo Nordisk's injectable semaglutide is no longer in shortage led to a significant decline in LFMD shares.
Revenue RiskInvestors are questioning the sustainability of revenue streams for LifeMD and other companies selling compounded forms of tirzepatide.
---
Ownership Overview
18.18% Insiders
9.09% Mutual Funds
8.62% Other Institutional Investors
56.65% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
LFMD FAQ
What was Lifemd, Inc.’s price range in the past 12 months?
Lifemd, Inc. lowest stock price was $3.99 and its highest was $12.88 in the past 12 months.
What is Lifemd, Inc.’s market cap?
Lifemd, Inc.’s market cap is $242.09M.
When is Lifemd, Inc.’s upcoming earnings report date?
Lifemd, Inc.’s upcoming earnings report date is May 09, 2025 which is in 36 days.
How were Lifemd, Inc.’s earnings last quarter?
Lifemd, Inc. released its earnings results on Mar 10, 2025. The company reported -$0.02 earnings per share for the quarter, beating the consensus estimate of -$0.051 by $0.031.
Is Lifemd, Inc. overvalued?
According to Wall Street analysts Lifemd, Inc.’s price is currently Undervalued.
Does Lifemd, Inc. pay dividends?
Lifemd, Inc. does not currently pay dividends.
What is Lifemd, Inc.’s EPS estimate?
Lifemd, Inc.’s EPS estimate is -0.05.
How many shares outstanding does Lifemd, Inc. have?
Lifemd, Inc. has 44,583,687 shares outstanding.
What happened to Lifemd, Inc.’s price movement after its last earnings report?
Lifemd, Inc. reported an EPS of -$0.02 in its last earnings report, beating expectations of -$0.051. Following the earnings report the stock price went up 30.679%.
Which hedge fund is a major shareholder of Lifemd, Inc.?
Currently, no hedge funds are holding shares in LFMD
---
LifeMD Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$11.42 (110.31% Upside)
$11.42 (110.31% Upside)
Blogger Sentiment
Bullish
LFMD Sentiment 70%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 54.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $299.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▼ 4.4%
Last 30 Days ▼ 4.4%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-43.33%
12-Months-Change
Fundamentals
Return on Equity
301.60%
Trailing 12-Months
Asset Growth
23.90%
Trailing 12-Months
Company Description
Lifemd, Inc.
LifeMD, Inc. (LFMD) is a leading telehealth company operating primarily in the United States. The company specializes in providing direct-to-patient healthcare services through its comprehensive telemedicine platform. LifeMD offers a range of services including virtual doctor consultations, personalized treatment plans, and prescription fulfillment. The company focuses on sectors such as primary care, dermatology, and men's health, aiming to make healthcare more accessible and convenient through digital means.
---
LFMD Company Deck
---
LFMD Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted strong growth in telehealth revenue and successful product launches, contributing to optimistic financial guidance for 2025. However, challenges such as declining gross margins and uncertainties in the compounded GLP-1 medication market were noted.Read More>---
LFMD Stock 12 Month Forecast
Average Price Target
$11.42
▲(110.31% Upside)
Technical Analysis
Best Analysts Covering LFMD
1 Year
1 Year Success Rate
4/10 ratings generated profit
1 Year Average Return
-8.25%
reiterated a buy rating 24 days ago
Copying Yi Chen's trades and holding each position for 1 Year would result in 40.00% of your transactions generating a profit, with an average return of -8.25% per trade.
---